Back

Association between body mass index and short-term mortality in cardiogenic shock patients supported by Impella: a multicenter retrospective study

30 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: The kidney and other comorbidities in cardiogenic shock Cardiogenic Shock ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Rui Nakano

Saiseikai Kumamoto Hospital, Kumamoto (Japan)

7 More presentations in this session

Presentation thumbnail
The heart-kidney connection: acute kidney injury in cardiogenic shock
Doctor R. Barbosa Sousa (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Impact of early enteral nutrition on delirium prevention in patients with malnutrition concurrent with acute myocardial infarction
Doctor H. Abe (Urayasu, JP)
Abstract Slides Video
Presentation thumbnail
Impact of DanGer Shock eligibility criteria on survival in patients with acute myocardial infarction-related cardiogenic shock: it is all about Impella?
Doctor D. Sa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Interaction between renal and right ventricular function and their early prognostic relevance in patients with cardiogenic shock complicating AMI
Doctor S. Dalanbaatar (Ulaanbaatar, MN)
Abstract Slides Video
Presentation thumbnail
Renal outcomes in patients requiring mechanical cardiac support: a comparison of micro-axial ventricular assist device to intra-aortic balloon pumping
Doctor H. Kusumoto (Takatsuki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
The kidney and other comorbidities in cardiogenic shock

The Event

Event poster

ESC Congress 2025

30 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Hemodynamic profile of obesity in cardiogenic shock
thumbnail
Congress Presentation
Obesity and outcomes in cardiogenic shock due to acute myocardial infarction
thumbnail
Congress Presentation
Impact of age and body mass index (BMI) on the short-term prognosis of Impella in patients with cardiogenic shock

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources